These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37848481)

  • 41. [First experience of using positron emission tomography with 11C-choline in prostate cancer (PC)].
    Granov AM; Tiutin LA; Ryzhkova DV; Shkol'nik MI; Andabekov TT; Mostova MI; Shatik SV; Kostenikov NA; Zaĭtsev VV; Tlostanova MS; Stanzhevskiĭ AA; Panfilenko AA; Arzumanov AA; Metelëv VV; Iliushchenko IuR
    Vopr Onkol; 2013; 59(4):460-4. PubMed ID: 24032219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
    Sutinen E; Nurmi M; Roivainen A; Varpula M; Tolvanen T; Lehikoinen P; Minn H
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):317-24. PubMed ID: 14628097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Magnetic Resonance Imaging With Positron Emission Tomography/Computed Tomography in the Evaluation of Response to Neoadjuvant Therapy of Breast Cancer.
    Baysal H; Serdaroglu AY; Ozemir IA; Baysal B; Gungor S; Erol CI; Ozsoy MS; Ekinci O; Alimoglu O
    J Surg Res; 2022 Oct; 278():223-232. PubMed ID: 35636197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Choline kinase and its function.
    Wu G; Vance DE
    Biochem Cell Biol; 2010 Aug; 88(4):559-64. PubMed ID: 20651826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
    Rinnab L; Blumstein NM; Mottaghy FM; Hautmann RE; Küfer R; Hohl K; Reske SN
    BJU Int; 2007 Jun; 99(6):1421-6. PubMed ID: 17355373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
    Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence.
    Ito K; Yokoyama J; Kubota K; Morooka M; Shiibashi M; Matsuda H
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1318-27. PubMed ID: 20306040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
    DeGrado TR; Baldwin SW; Wang S; Orr MD; Liao RP; Friedman HS; Reiman R; Price DT; Coleman RE
    J Nucl Med; 2001 Dec; 42(12):1805-14. PubMed ID: 11752077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.
    Ceci F; Castellucci P; Graziani T; Schiavina R; Brunocilla E; Mazzarotto R; Ntreta M; Lodi F; Martorana G; Fanti S
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):878-86. PubMed ID: 24346416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [¹¹C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy.
    Giovacchini G; Incerti E; Mapelli P; Kirienko M; Briganti A; Gandaglia G; Montorsi F; Gianolli L; Picchio M
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):877-84. PubMed ID: 25697127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI.
    Yoon H; Yoon D; Yun M; Choi JS; Park VY; Kim EK; Jeong J; Koo JS; Yoon JH; Moon HJ; Kim S; Kim MJ
    PLoS One; 2016; 11(7):e0159949. PubMed ID: 27459480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer.
    Backhaus P; Burg MC; Roll W; Büther F; Breyholz HJ; Weigel S; Heindel W; Pixberg M; Barth P; Tio J; Schäfers M
    Radiology; 2022 Jan; 302(1):39-47. PubMed ID: 34636633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.
    Schwarzenböck SM; Schmeja P; Kurth J; Souvatzoglou M; Nawroth R; Treiber U; Kundt G; Berndt S; Graham K; Senekowitsch-Schmidtke R; Schwaiger M; Ziegler SI; Dinkelborg L; Wester HJ; Krause BJ
    Mol Imaging Biol; 2016 Jun; 18(3):393-401. PubMed ID: 26483088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
    Morris PG; Ulaner GA; Eaton A; Fazio M; Jhaveri K; Patil S; Evangelista L; Park JY; Serna-Tamayo C; Howard J; Larson S; Hudis CA; McArthur HL; Jochelson MS
    Cancer; 2012 Nov; 118(22):5454-62. PubMed ID: 22517371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [11C]choline positron emission tomography in estrogen receptor-positive breast cancer.
    Contractor KB; Kenny LM; Stebbing J; Al-Nahhas A; Palmieri C; Sinnett D; Lewis JS; Hogben K; Osman S; Shousha S; Lowdell C; Coombes RC; Aboagye EO
    Clin Cancer Res; 2009 Sep; 15(17):5503-10. PubMed ID: 19706823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of PET/CT and VATS for detecting and treating internal mammary lymph node metastasis: a case series.
    Kawaguchi S; Tamura N; Suzuki S; Nishikawa A; Shibata A; Tanaka K; Kobayashi Y; Ogura T; Sato J; Kinowaki K; Shiiba M; Ishihara M; Fujimori S; Kawabata H
    Jpn J Clin Oncol; 2023 Jun; 53(7):562-571. PubMed ID: 37057634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency and Characteristics of Nodal and Deltoid FDG and
    Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
    AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
    [No Abstract]   [Full Text] [Related]  

  • 59. PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy.
    Giovacchini G; Picchio M; Scattoni V; Garcia Parra R; Briganti A; Gianolli L; Montorsi F; Messa C
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1106-16. PubMed ID: 20306038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of ¹¹C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation.
    Bertagna F; Abuhilal M; Bosio G; Simeone C; Rossini P; Pizzocaro C; Orlando E; Finamanti M; Biasiotto G; Rodella C; Cosciani Cunico S; Giubbini R
    Jpn J Radiol; 2011 Jul; 29(6):394-404. PubMed ID: 21786095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.